Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of €160.16 million as of August 14, 2025. Its market cap has decreased by -0.45% in one year.

Market Cap

160.16M

Enterprise Value

200.62M

Revenue

51.39M

Ranking

n/a

PE Ratio

10.11

Stock Price

€8.02

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 194.15M to 160.16M, a decrease of -17.51%. That is a compound annual growth rate of -1.03%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	160.16M	-13.46%
Dec 30, 2024	185.06M	94.99%
Dec 29, 2023	94.91M	239.07%
Dec 30, 2022	27.99M	0.21%
Dec 30, 2021	27.93M	-20.96%
Dec 30, 2020	35.34M	-66.13%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	270.19B
Siemens Aktiengesellschaft	179.63B
Deutsche Telekom AG	147.71B
Allianz SE	138.79B
Siemens Energy AG	77.82B
Rheinmetall AG	73.17B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	72.32B
Deutsche Bank Aktiengesellschaft	59.40B

Market Cap Rankings